Clinica Baviera (CBAV) - Total Assets
Based on the latest financial reports, Clinica Baviera (CBAV) holds total assets worth €228.01 Million EUR (≈ $266.57 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Clinica Baviera (CBAV) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Clinica Baviera - Total Assets Trend (2005–2024)
This chart illustrates how Clinica Baviera's total assets have evolved over time, based on quarterly financial data. See what is Clinica Baviera's book value for net asset value and shareholders' equity analysis.
Clinica Baviera - Asset Composition Analysis
Current Asset Composition (December 2024)
Clinica Baviera's total assets of €228.01 Million consist of 22.6% current assets and 77.4% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 4.8% |
| Accounts Receivable | €4.82 Million | 2.3% |
| Inventory | €3.28 Million | 1.6% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €8.73 Million | 4.1% |
| Goodwill | €28.31 Million | 13.4% |
Asset Composition Trend (2005–2024)
This chart illustrates how Clinica Baviera's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Clinica Baviera worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Clinica Baviera's current assets represent 22.6% of total assets in 2024, a decrease from 69.6% in 2005.
- Cash Position: Cash and equivalents constituted 4.8% of total assets in 2024, down from 58.8% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, an increase from 0.0% in 2005.
- Asset Diversification: The largest asset category is goodwill at 13.4% of total assets.
Clinica Baviera Competitors by Total Assets
Key competitors of Clinica Baviera based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
|
China | CN¥9.20 Billion |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Cryosite Ltd
AU:CTE
|
Australia | AU$26.55 Million |
|
Microba Life Sciences Ltd
AU:MAP
|
Australia | AU$43.35 Million |
Clinica Baviera - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.53 | 0.80 | 0.97 |
| Quick Ratio | 1.53 | 0.80 | 0.92 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €18.40 Million | €-10.43 Million | €-969.98K |
Clinica Baviera - Advanced Valuation Insights
This section examines the relationship between Clinica Baviera's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.80 |
| Latest Market Cap to Assets Ratio | 3.97 |
| Asset Growth Rate (YoY) | 18.6% |
| Total Assets | €211.95 Million |
| Market Capitalization | $842.36 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Clinica Baviera's assets at a significant premium (3.97x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Clinica Baviera's assets grew by 18.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Clinica Baviera (2005–2024)
The table below shows the annual total assets of Clinica Baviera from 2005 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €211.95 Million ≈ $247.80 Million |
+18.65% |
| 2023-12-31 | €178.64 Million ≈ $208.85 Million |
+19.01% |
| 2022-12-31 | €150.10 Million ≈ $175.49 Million |
+12.18% |
| 2021-12-31 | €133.81 Million ≈ $156.44 Million |
+10.66% |
| 2020-12-31 | €120.92 Million ≈ $141.37 Million |
+19.06% |
| 2019-12-31 | €101.56 Million ≈ $118.74 Million |
+81.92% |
| 2018-12-31 | €55.83 Million ≈ $65.27 Million |
+3.40% |
| 2017-12-31 | €53.99 Million ≈ $63.12 Million |
+15.45% |
| 2016-12-31 | €46.77 Million ≈ $54.68 Million |
+0.84% |
| 2015-12-31 | €46.38 Million ≈ $54.22 Million |
-5.42% |
| 2014-12-31 | €49.04 Million ≈ $57.33 Million |
+1.57% |
| 2013-12-31 | €48.28 Million ≈ $56.44 Million |
-6.56% |
| 2012-12-31 | €51.67 Million ≈ $60.40 Million |
-10.70% |
| 2011-12-31 | €57.86 Million ≈ $67.64 Million |
+1.78% |
| 2010-12-31 | €56.84 Million ≈ $66.45 Million |
-3.25% |
| 2009-12-31 | €58.75 Million ≈ $68.69 Million |
-8.37% |
| 2008-12-31 | €64.12 Million ≈ $74.96 Million |
+41.71% |
| 2007-12-31 | €45.25 Million ≈ $52.90 Million |
+4.28% |
| 2006-12-31 | €43.39 Million ≈ $50.73 Million |
+44.10% |
| 2005-12-31 | €30.11 Million ≈ $35.20 Million |
-- |
About Clinica Baviera
Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics in Spain and Europe. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, farsightedness, presbyopia, cataract, retinal, plastic surgery, pediatric ophthalmology, glaucoma, strabismus, cornea, neuro-ophthalmol… Read more